Global Human Insulin Market Research Report 2021
Table of Contents1 Human Insulin Market Overview
1.1 Product Overview and Scope of Human Insulin
1.2 Human Insulin Segment by Type
1.2.1 Global Human Insulin Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Insulin Analogs and Biosimilars
1.2.3 Human Insulin Biologics
1.3 Human Insulin Segment by Application
1.3.1 Human Insulin Sales Comparison by Application: (2021-2027)
1.3.2 Short acting
1.3.3 Intermediate acting
1.3.4 Long acting
1.3.5 Pre-mix Insulin
1.4 Global Human Insulin Market Size Estimates and Forecasts
1.4.1 Global Human Insulin Revenue 2016-2027
1.4.2 Global Human Insulin Sales 2016-2027
1.4.3 Human Insulin Market Size by Region: 2016 Versus 2021 Versus 2027
2 Human Insulin Market Competition by Manufacturers
2.1 Global Human Insulin Sales Market Share by Manufacturers (2016-2021)
2.2 Global Human Insulin Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Human Insulin Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Human Insulin Manufacturing Sites, Area Served, Product Type
2.5 Human Insulin Market Competitive Situation and Trends
2.5.1 Human Insulin Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Human Insulin Players Market Share by Revenue
2.5.3 Global Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Insulin Retrospective Market Scenario by Region
3.1 Global Human Insulin Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Human Insulin Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Human Insulin Market Facts & Figures by Country
3.3.1 North America Human Insulin Sales by Country
3.3.2 North America Human Insulin Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Human Insulin Market Facts & Figures by Country
3.4.1 Europe Human Insulin Sales by Country
3.4.2 Europe Human Insulin Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Human Insulin Market Facts & Figures by Region
3.5.1 Asia Pacific Human Insulin Sales by Region
3.5.2 Asia Pacific Human Insulin Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Human Insulin Market Facts & Figures by Country
3.6.1 Latin America Human Insulin Sales by Country
3.6.2 Latin America Human Insulin Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Human Insulin Market Facts & Figures by Country
3.7.1 Middle East and Africa Human Insulin Sales by Country
3.7.2 Middle East and Africa Human Insulin Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Human Insulin Historic Market Analysis by Type
4.1 Global Human Insulin Sales Market Share by Type (2016-2021)
4.2 Global Human Insulin Revenue Market Share by Type (2016-2021)
4.3 Global Human Insulin Price by Type (2016-2021)
5 Global Human Insulin Historic Market Analysis by Application
5.1 Global Human Insulin Sales Market Share by Application (2016-2021)
5.2 Global Human Insulin Revenue Market Share by Application (2016-2021)
5.3 Global Human Insulin Price by Application (2016-2021)
6 Key Companies Profiled
6.1 B. Braun
6.1.1 B. Braun Corporation Information
6.1.2 B. Braun Description and Business Overview
6.1.3 B. Braun Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.1.4 B. Braun Product Portfolio
6.1.5 B. Braun Recent Developments/Updates
6.2 Becton, Dickinson
6.2.1 Becton, Dickinson Corporation Information
6.2.2 Becton, Dickinson Description and Business Overview
6.2.3 Becton, Dickinson Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Becton, Dickinson Product Portfolio
6.2.5 Becton, Dickinson Recent Developments/Updates
6.3 Biocon
6.3.1 Biocon Corporation Information
6.3.2 Biocon Description and Business Overview
6.3.3 Biocon Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Biocon Product Portfolio
6.3.5 Biocon Recent Developments/Updates
6.4 Biodel
6.4.1 Biodel Corporation Information
6.4.2 Biodel Description and Business Overview
6.4.3 Biodel Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Biodel Product Portfolio
6.4.5 Biodel Recent Developments/Updates
6.5 ELI Lilly
6.5.1 ELI Lilly Corporation Information
6.5.2 ELI Lilly Description and Business Overview
6.5.3 ELI Lilly Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.5.4 ELI Lilly Product Portfolio
6.5.5 ELI Lilly Recent Developments/Updates
6.6 Julphar
6.6.1 Julphar Corporation Information
6.6.2 Julphar Description and Business Overview
6.6.3 Julphar Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Julphar Product Portfolio
6.6.5 Julphar Recent Developments/Updates
6.7 NOVO Nordisk
6.6.1 NOVO Nordisk Corporation Information
6.6.2 NOVO Nordisk Description and Business Overview
6.6.3 NOVO Nordisk Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.4.4 NOVO Nordisk Product Portfolio
6.7.5 NOVO Nordisk Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Sanofi Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Wockhardt
6.9.1 Wockhardt Corporation Information
6.9.2 Wockhardt Description and Business Overview
6.9.3 Wockhardt Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Wockhardt Product Portfolio
6.9.5 Wockhardt Recent Developments/Updates
6.10 Ypsomed
6.10.1 Ypsomed Corporation Information
6.10.2 Ypsomed Description and Business Overview
6.10.3 Ypsomed Human Insulin Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Ypsomed Product Portfolio
6.10.5 Ypsomed Recent Developments/Updates
7 Human Insulin Manufacturing Cost Analysis
7.1 Human Insulin Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Human Insulin
7.4 Human Insulin Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Human Insulin Distributors List
8.3 Human Insulin Customers
9 Human Insulin Market Dynamics
9.1 Human Insulin Industry Trends
9.2 Human Insulin Growth Drivers
9.3 Human Insulin Market Challenges
9.4 Human Insulin Market Restraints
10 Global Market Forecast
10.1 Human Insulin Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Human Insulin by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Human Insulin by Type (2022-2027)
10.2 Human Insulin Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Human Insulin by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Human Insulin by Application (2022-2027)
10.3 Human Insulin Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Human Insulin by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Human Insulin by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global Human Insulin Sales (K Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Human Insulin Sales (K Doses) Comparison by Application (2021-2027)
Table 3. Global Human Insulin Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Human Insulin Covered in This Study
Table 5. Global Human Insulin Sales (K Doses) of Key Manufacturers (2016-2021)
Table 6. Global Human Insulin Sales Share by Manufacturers (2016-2021)
Table 7. Global Human Insulin Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Human Insulin Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Human Insulin Average Price (USD/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Human Insulin Manufacturing Sites and Area Served
Table 11. Manufacturers Human Insulin Product Type
Table 12. Global Human Insulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Human Insulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Insulin as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Human Insulin Sales by Region (2016-2021) & (K Doses)
Table 16. Global Human Insulin Sales Market Share by Region (2016-2021)
Table 17. Global Human Insulin Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Human Insulin Sales by Country (2016-2021) & (K Doses)
Table 19. North America Human Insulin Sales Market Share by Country (2016-2021)
Table 20. North America Human Insulin Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Human Insulin Revenue Market Share by Country (2016-2021)
Table 22. Europe Human Insulin Sales by Country (2016-2021) & (K Doses)
Table 23. Europe Human Insulin Sales Market Share by Country (2016-2021)
Table 24. Europe Human Insulin Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Human Insulin Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Human Insulin Sales by Region (2016-2021) & (K Doses)
Table 27. Asia Pacific Human Insulin Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Human Insulin Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Human Insulin Revenue Market Share by Region (2016-2021)
Table 30. Latin America Human Insulin Sales by Country (2016-2021) & (K Doses)
Table 31. Latin America Human Insulin Sales Market Share by Country (2016-2021)
Table 32. Latin America Human Insulin Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Human Insulin Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Human Insulin Sales by Country (2016-2021) & (K Doses)
Table 35. Middle East and Africa Human Insulin Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Human Insulin Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Human Insulin Revenue Market Share by Country (2016-2021)
Table 38. Global Human Insulin Sales (K Doses) by Type (2016-2021)
Table 39. Global Human Insulin Sales Market Share by Type (2016-2021)
Table 40. Global Human Insulin Revenue (Million US$) by Type (2016-2021)
Table 41. Global Human Insulin Revenue Share by Type (2016-2021)
Table 42. Global Human Insulin Price (USD/Dose) by Type (2016-2021)
Table 43. Global Human Insulin Sales (K Doses) by Application (2016-2021)
Table 44. Global Human Insulin Sales Market Share by Application (2016-2021)
Table 45. Global Human Insulin Revenue (Million US$) by Application (2016-2021)
Table 46. Global Human Insulin Revenue Share by Application (2016-2021)
Table 47. Global Human Insulin Price (USD/Dose) by Application (2016-2021)
Table 48. B. Braun Corporation Information
Table 49. B. Braun Description and Business Overview
Table 50. B. Braun Human Insulin Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 51. B. Braun Human Insulin Product
Table 52. B. Braun Recent Developments/Updates
Table 53. Becton, Dickinson Corporation Information
Table 54. Becton, Dickinson Description and Business Overview
Table 55. Becton, Dickinson Human Insulin Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 56. Becton, Dickinson Human Insulin Product
Table 57. Becton, Dickinson Recent Developments/Updates
Table 58. Biocon Corporation Information
Table 59. Biocon Description and Business Overview
Table 60. Biocon Human Insulin Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 61. Biocon Human Insulin Product
Table 62. Biocon Recent Developments/Updates
Table 63. Biodel Corporation Information
Table 64. Biodel Description and Business Overview
Table 65. Biodel Human Insulin Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 66. Biodel Human Insulin Product
Table 67. Biodel Recent Developments/Updates
Table 68. ELI Lilly Corporation Information
Table 69. ELI Lilly Description and Business Overview
Table 70. ELI Lilly Human Insulin Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 71. ELI Lilly Human Insulin Product
Table 72. ELI Lilly Recent Developments/Updates
Table 73. Julphar Corporation Information
Table 74. Julphar Description and Business Overview
Table 75. Julphar Human Insulin Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 76. Julphar Human Insulin Product
Table 77. Julphar Recent Developments/Updates
Table 78. NOVO Nordisk Corporation Information
Table 79. NOVO Nordisk Description and Business Overview
Table 80. NOVO Nordisk Human Insulin Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 81. NOVO Nordisk Human Insulin Product
Table 82. NOVO Nordisk Recent Developments/Updates
Table 83. Sanofi Corporation Information
Table 84. Sanofi Description and Business Overview
Table 85. Sanofi Human Insulin Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 86. Sanofi Human Insulin Product
Table 87. Sanofi Recent Developments/Updates
Table 88. Wockhardt Corporation Information
Table 89. Wockhardt Description and Business Overview
Table 90. Wockhardt Human Insulin Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 91. Wockhardt Human Insulin Product
Table 92. Wockhardt Recent Developments/Updates
Table 93. Ypsomed Corporation Information
Table 94. Ypsomed Description and Business Overview
Table 95. Ypsomed Human Insulin Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 96. Ypsomed Human Insulin Product
Table 97. Ypsomed Recent Developments/Updates
Table 98. Production Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Human Insulin Distributors List
Table 101. Human Insulin Customers List
Table 102. Human Insulin Market Trends
Table 103. Human Insulin Growth Drivers
Table 104. Human Insulin Market Restraints
Table 105. Global Human Insulin Sales Forecast by Type (2022-2027) & (K Doses)
Table 106. Global Human Insulin Sales Market Share Forecast by Type (2022-2027)
Table 107. Global Human Insulin Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 108. Global Human Insulin Revenue Market Share Forecast by Type (2022-2027)
Table 109. Global Human Insulin Sales Forecast by Application (2022-2027) & (K Doses)
Table 110. Global Human Insulin Sales Market Share Forecast by Application (2022-2027)
Table 111. Global Human Insulin Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 112. Global Human Insulin Revenue Market Share Forecast by Application (2022-2027)
Table 113. Global Human Insulin Sales Forecast by Region (2022-2027) & (K Doses)
Table 114. Global Human Insulin Sales Market Share Forecast by Region (2022-2027)
Table 115. Global Human Insulin Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 116. Global Human Insulin Revenue Market Share Forecast by Region (2022-2027)
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of FiguresFigure 1. Product Picture of Human Insulin
Figure 2. Global Human Insulin Market Share by Type in 2020 & 2027
Figure 3. Insulin Analogs and Biosimilars Product Picture
Figure 4. Human Insulin Biologics Product Picture
Figure 5. Global Human Insulin Market Share by Application in 2020 & 2027
Figure 6. Short acting
Figure 7. Intermediate acting
Figure 8. Long acting
Figure 9. Pre-mix Insulin
Figure 10. Global Human Insulin Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Human Insulin Market Size 2016-2027 (US$ Million)
Figure 12. Global Human Insulin Sales 2016-2027 (K Doses)
Figure 13. Global Human Insulin Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Human Insulin Sales Share by Manufacturers in 2020
Figure 15. Global Human Insulin Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Human Insulin Players: Market Share by Revenue in 2020
Figure 17. Human Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Human Insulin Sales Market Share by Region (2016-2021)
Figure 19. Global Human Insulin Sales Market Share by Region in 2020
Figure 20. Global Human Insulin Revenue Market Share by Region (2016-2021)
Figure 21. Global Human Insulin Revenue Market Share by Region in 2020
Figure 22. U.S. Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Human Insulin Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Human Insulin by Type (2016-2021)
Figure 47. Sales Market Share of Human Insulin by Application (2016-2021)
Figure 48. Sales Market Share of Human Insulin by Application in 2020
Figure 49. Revenue Share of Human Insulin by Application (2016-2021)
Figure 50. Revenue Share of Human Insulin by Application in 2020
Figure 51. Manufacturing Cost Structure of Human Insulin
Figure 52. Manufacturing Process Analysis of Human Insulin
Figure 53. Human Insulin Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed